News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Celldex Therapeutics, Inc. (CLDX) Shares Fall Following Study Update; Celldex Called Buying Opportunity After Data Snafu



5/21/2010 11:50:33 AM

NEW YORK, May 21 (Reuters) - Industry analysts said a selloff of Celldex Therapeutics Inc (CLDX.O) shares was caused by misinterpretation of favorable data from a study of its experimental brain cancer drug, creating a buying opportunity for investors.

Read at Reuters
Read at CNBC
Read at Business Week


comments powered by Disqus
Reuters
CNBC
Business Week
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES